Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03725852
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 68
Testing effectiveness (Phase 2)Study completedNCT02538536
What this trial is testing

Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Liminal BioSciences Ltd. 41
Testing effectiveness (Phase 2)UnknownNCT03548181
What this trial is testing

Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Aarhus 30
Not applicableStudy completedNCT03499275
What this trial is testing

Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 23
Not applicableStudy completedNCT01118221
What this trial is testing

Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
US Department of Veterans Affairs 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583589
What this trial is testing

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
First Affiliated Hospital of Wenzhou Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT01432080
What this trial is testing

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Who this might be right for
Respiratory Tract InfectionsBronchiolitis ObliteransCryptogenic Organizing Pneumonia+1 more
Maisonneuve-Rosemont Hospital 12
Early research (Phase 1)Study completedNCT06625489
What this trial is testing

Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 50
Not applicableStudy completedNCT03732859
What this trial is testing

PROOF-Registry New and Extended Belgium -Luxembourg

Who this might be right for
Idiopathic Pulmonary Fibrosis
Belgian Thoracic Society 575
Not applicableUnknownNCT01088217
What this trial is testing

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisFamilial Pulmonary FibrosisIdiopathic Interstitial Pneumonia+1 more
National Jewish Health 8,000
Not applicableUnknownNCT05863091
What this trial is testing

Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.

Who this might be right for
Pulmonary Disease, Chronic ObstructiveIdiopathic Pulmonary FibrosisAsthma
Yonsei University 211
Testing effectiveness (Phase 2)Ended earlyNCT03142191
What this trial is testing

Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisFibrosisIdiopathic Interstitial Pneumonias+4 more
Celgene 138
Testing effectiveness (Phase 2)Ended earlyNCT05785624
What this trial is testing

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisSystemic Sclerosis With Lung Involvement
Genentech, Inc. 286
Not applicableStudy completedNCT07686562
What this trial is testing

Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography

Who this might be right for
Lung Disease, InterstitialIdiopathic Pulmonary Fibrosis (IPF)Incidental Findings+2 more
Chung-Ang University Hospital 1,293
Not applicableStudy completedNCT01789996
What this trial is testing

The Six Minute Walk Test: Influence of Instruction on Results

Who this might be right for
Interstitial Lung Disease
Inova Health Care Services 45
Not applicableStudy completedNCT02019641
What this trial is testing

The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisInterstitial Pneumonitis+1 more
National Institutes of Health Clinical Center (CC) 46
Not applicableEnded earlyNCT04263727
What this trial is testing

Patients With Chronic Disease

Who this might be right for
AsthmaChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis+3 more
Target PharmaSolutions, Inc. 579
Large-scale testing (Phase 3)Study completedNCT00287729
What this trial is testing

Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 344
Very early researchUnknownNCT05052229
What this trial is testing

Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).

Who this might be right for
Idiopathic Pulmonary Fibrosis
Dr. Denis O'Donnell 40
Testing effectiveness (Phase 2)Study completedNCT04318704
What this trial is testing

Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

Who this might be right for
Idiopathic Pulmonary Fibrosis
Algernon Pharmaceuticals 20
Next Page